AHA yesterday submitted policy recommendations to House Ways and Means Committee leaders as they begin developing Medicare-related legislation to address the opioid crisis. The committee is seeking feedback on specific questions related to overprescribing, data tracking, beneficiary notification, provider education, and treatment options. AHA also has submitted recommendations to other committees of jurisdiction, as Congress plans to enact comprehensive legislation on opioids this spring. 

Related News Articles

Headline
The Centers for Medicare & Medicaid Services June 28 released a proposed rule on mitigating the impact of significant, anomalous and highly suspect (SAHS)…
Headline
The Department of Health and Human Services June 26 announced beneficiary coinsurance reductions for 64 prescription drugs available through Medicare Part B.…
Blog
Last week, several academics released a working paper saying hospital prices lead to employment losses outside the health sector, among other faulty…
Headline
AHA and the Institute for Diversity and Health Equity recently released the fourth of its five-part DEI Data Insights series, which highlights results from the…
Perspective
For too long and for too many patients, the process of obtaining prior authorization for a medical procedure or medicine has been a tangled web, as people are…
Headline
Juneteenth reminds us of the enduring legacy of systemic inequities and the ongoing calling to dismantle them, wherever they exist, writes Daniel E. Dawes,…